BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20001410)

  • 1. Use of administrative data for the surveillance of mood and anxiety disorders.
    Kisely S; Lin E; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1118-25. PubMed ID: 20001410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of administrative data for the surveillance of mental disorders in 5 provinces.
    Kisely S; Lin E; Lesage A; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Can J Psychiatry; 2009 Aug; 54(8):571-5. PubMed ID: 19726010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of mood and anxiety disorders in Australian women.
    Williams L; Jacka F; Pasco J; Henry M; Dodd S; Nicholson G; Kotowicz M; Berk M
    Australas Psychiatry; 2010 Jun; 18(3):250-5. PubMed ID: 20482429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
    Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders.
    Walker JR; Ediger JP; Graff LA; Greenfeld JM; Clara I; Lix L; Rawsthorne P; Miller N; Rogala L; McPhail CM; Bernstein CN
    Am J Gastroenterol; 2008 Aug; 103(8):1989-97. PubMed ID: 18796096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sample.
    Patten SB; Williams JV
    Psychosomatics; 2007; 48(6):496-501. PubMed ID: 18071096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey.
    Levinson D; Zilber N; Lerner Y; Grinshpoon A; Levav I
    Isr J Psychiatry Relat Sci; 2007; 44(2):94-103. PubMed ID: 18080646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data.
    O'Donnell S; Vanderloo S; McRae L; Onysko J; Patten SB; Pelletier L
    Epidemiol Psychiatr Sci; 2016 Aug; 25(4):360-9. PubMed ID: 26081585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study.
    Huang KL; Su TP; Chen TJ; Chou YH; Bai YM
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):401-9. PubMed ID: 19566773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive epidemiology of osteoarthritis in British Columbia, Canada.
    Kopec JA; Rahman MM; Berthelot JM; Le Petit C; Aghajanian J; Sayre EC; Cibere J; Anis AH; Badley EM
    J Rheumatol; 2007 Feb; 34(2):386-93. PubMed ID: 17183616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a U-shaped relationship exist between alcohol use and DSM-III-R mood and anxiety disorders?
    Sareen J; McWilliams L; Cox B; Stein MB
    J Affect Disord; 2004 Oct; 82(1):113-8. PubMed ID: 15465583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.
    Grant BF; Hasin DS; Stinson FS; Dawson DA; Patricia Chou S; June Ruan W; Huang B
    J Psychiatr Res; 2005 Jan; 39(1):1-9. PubMed ID: 15504418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age shall not weary them: mental health in the middle-aged and the elderly.
    Trollor JN; Anderson TM; Sachdev PS; Brodaty H; Andrews G
    Aust N Z J Psychiatry; 2007 Jul; 41(7):581-9. PubMed ID: 17558620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
    Bunevicius R; Velickiene D; Prange AJ
    Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence of mental disorders in the Greater-Reykjavik area].
    Stefánsson JG; Líndal E
    Laeknabladid; 2009 Sep; 95(9):559-64. PubMed ID: 19738288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of obesity with mood and anxiety disorders in the adult general population.
    Gadalla TM
    Chronic Dis Can; 2009; 30(1):29-36. PubMed ID: 20031086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.